{"id":6328,"date":"2002-03-10T11:37:13","date_gmt":"2002-03-10T10:37:13","guid":{"rendered":"http:\/\/moomango.co.uk\/htb\/?p=6328"},"modified":"2014-06-05T14:26:20","modified_gmt":"2014-06-05T14:26:20","slug":"il-2-promiscuous-cytokine-or-steady-date","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/6328","title":{"rendered":"IL-2: promiscuous cytokine or steady date"},"content":{"rendered":"<p><strong>Tracy Swan<\/strong><br \/>\nACRIA Update, Vol. 11, No. 1, Winter 2001\/2002<\/p>\n<p><strong>Interleukin-2 (IL-2) is the immune-based therapy that has been most extensively studied in HIV.<\/strong><\/p>\n<p>Many people continue to be intrigued by its potential, yet questions about IL-2 remain unanswered, including the most basic one \u2014 is it an effective HIV therapy? IL-2 has also been called an immune booster, an immune modulator and T-cell growth factor.<\/p>\n<p>A man-made form of IL-2 was first developed in the early 1980s as a treatment for certain cancers. Although IL-2 has been studied in people with HIV since the 1980s, it hasn\u2019t been approved as a treatment for HIV disease.<\/p>\n<p><a href=\"http:\/\/ww2.aegis.org\/pubs\/cria\/2001\/CR110103.html\">http:\/\/ww2.aegis.org\/pubs\/cria\/2001\/CR110103.html<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tracy Swan ACRIA Update, Vol. 11, No. 1, Winter 2001\/2002 Interleukin-2 (IL-2) is the immune-based therapy that has been most extensively studied in HIV. Many people continue to be intrigued by its potential, yet questions about IL-2 remain unanswered, including &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[],"class_list":["post-6328","post","type-post","status-publish","format-standard","hentry","category-on-the-web"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6328","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=6328"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/6328\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=6328"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=6328"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=6328"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}